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A normal fibrotic response to inflammatory stimuli 
appears to be dependent on the balanced production of 
a number of stimulatory and inhibitory fibroblast-reg-
ulatory mediators by activated mononuclear cells 
(MNL). To investigate whether altered mediator pro-
duction contributes to the fibrosis observed in progres-
sive systemic sclerosis (PSS), we stimulated human pe-
ripheral blood MNL with concanavalin A (Con A) and 
lipopolysaccharide (LPS) to produce macromolecular 
mediators that inhibit the proliferation and the collagen 
production of cultured normal human fibroblasts. The 
two Con A-induced mediators were lymphokines (LK) 
as they were exclusively produced by activated T cells 
and they coeluted from a Sephacryl S-200 column with 
a Mr of 50,000. In contrast, the two LPS-induced me-
diators were monokines (MK) as they were exclusively 
produced by activated monocytes, and they coeluted in 
the Mr 20,000 range. Each pair of inhibitory LK and 
MK may also be distinct as inhibition of collagen pro-
duction still occurred in proliferatively quiescent cul-
tures. A quantitative comparison of the levels of fibro-
blast-inhibitory LK/MK produced by normal volunteers 
and long-term PSS patients revealed that although PSS 
M NL produced normal levels of both collagen produc-
t ion inhibitory mediators, they were aberrant producers 
of both proliferation inhibitory mediators, being hypo-
producers (-49%) of the LK and hyperproducers 
(+196%) of the MK. These results suggest that reduced 
production of proliferation inhibitory LK may allow 
stimulatory mediators to induce the unrestricted fibro-
blast proliferation observed in early active PSS, which 
then may be stabilized in long-term PSS by the increased 
production of proliferation inhibitory MK. 
It h as long been recognized that chronic inflammatory lesions 
that are characteri z-ed by infil t rating lymphocytes and mono-
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cytes are also associated wi th an increased fibroblast population 
and the subsequent fo rmation of fibrotic t issue [1- 7]. This 
pathologic association of mononuclear cells (MNL) and fibro-
blasts in vivo has recently led to the in vitro investigation of 
the role activated MNL play in producing a normal fibrotic 
response. A compilation of t hese studies suggests t.hat a normal 
fibrotic response is t he result of t he carefully balanced produc-
tion by activated MNL of a number ofT cell-derived lympho-
kines (LK) and monocyte-derived monokines (MK) with an-
tago nistic fibroblast-regu latory activi t ies. To date, both LK 
and MK preparations have been described with activi t ies both 
as stimulators and as inhibitors of fibroblast movement [8-
10), proliferation [11- 16), and protein production, including 
t he fibrosis forming coll agens and glycosaminoglycans [17-
22]. How the normal balance of stimulatory and inhibitory 
activities is altered to produce pathologic fibrosis is currently 
under investigation in a number of inflammation-associated 
disorders [23,24]. 
Progressive systemic scleros is (PSS, scleroderma) is a con-
nective tissue disease of unknown etiology characterized by 
cuta neous and visceral fibrosis, which during its early stages is 
associated with extensive MNL infiltration of the t issue sites 
that later become fibrotic [6,25- 27]. The MNL infil trates are 
composed primarily of T cells and monocytes/ macrophages, 
along with smaller numbers of B and plasma cells, and the 
MNL are accompanied by an increased fibroblast population , 
a portion of which are hyperproducers of collagen [28,29]. How 
LK/ MK-mediated mechanisms cont ribute to increasing fibro-
blast number and function in vivo in PSS is unknown at 
present, but it may involve t he unbalanced production of stim-
ulatory and inhibitory LK/MK by the T cell and monocyte/ 
macrophage populations infiltrating the PSS tissue site. While 
t he T cell s and monocytes/macrophages present in PSS loci 
have yet to be functionally classified, studies employi ng periph-
eral blood MNL indicate t hat PSS is associated both with 
reduced T suppressor ce ll numbers and with increased suppres-
sor monocyte activity [30- 34]. Since aberrant suppressor cell 
number/ function should logically be accompanied by t he aber-
rant production of LK/ MK with suppressive or inhibitory 
activities, we in t his report have investigated t he production of 
the LK and MK inhibiting fibroblast proliferation and collagen 
synthesis by peripheral blood MNL from patients with PSS. 
The reduced production of any of t hese inhibitory LK/ MK 
would result in a relative excess of t he corresponding stimula-
tory mediator being present in the PSS loci, which could induce 
the increased fibroblast pro li feration and unregu lated collagen 
production obse rved in PSS. 
In order to be able to discriminately assess t he production of 
fibrob last- inhibitory LK/MK in PSS we first optimized the 
culture conditions necessa ry for the production and assay of 
LK/ MK supernatants. This enabled us to assay MNL super-
natants for fibrobl ast- inhibi to ry activities without in te rference 
from fibrobl ast-stimulatory activities, as well as to assay LK 
activity separately from MK activity, and collagen synthesis 
inhibitory activity separately from fibroblast prolife ration in-
hibi tory activity. Our res4lts suggest that t he LK and MK 
inhibiting fibroblast prolife ration and co llagen production may 
be 4 distinct factors, and moreove r, in the long-term patients 
studied , PSS is associated not only with a defi cient production 
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of lhe LK inhibiling fibroblast proliferat ion but also with the 
elevated production of the analogous MK. 
MATERIALS AND METHODS 
Patient and No rmal Populations 
The patient group consisted of 13 fema les ra nging in age from 20-
75 yea rs (mean , 50.3 yea rs). All pat ients met t he criteria for diagnosis 
of PSS a nd had a di sease duration ranging from :l- 20 yea rs (mean , 9.6 
yea rs) . The pa t ient group included both t hose wh o displayed PSS with 
diffuse scleroderma a nd those wit h PSS with t he CREST syndrome 
[:J5 j. None of the patients was receiving corticosteroids, D-penicilla-
mine, or cytotox ic drugs at t he t ime of ve nipuncture. Informed consent 
was obta ined fro m all pat ients a nd these studies were approved by the 
Mount Sinai Sc hool of Medicine Huma n Subjects Committee . The 
norma l cont rol group consisted of 14 healthy vo luntee rs a nd hospital 
perso nnel, and included l 0 females a nd 4 males ranging in age from 
24 - 58 years (mea n, 36.2 years). 
Preparation of M N L 
All procedures used to prepare MNL a nd to ge nerate LK/ M K 
supern atants were performed wit h medi a a nd reagents judged to con-
ta in Jess than 0.07 ng/ml endotox in by t.he Limulus a mebocyte lysate 
assay (MA Bioproducts, Walkersville, Maryla nd). Huma n peripheral 
hlood MNL were recovered by Ficoll -1-l ypaque fractionation (Ficoii -
Paque, Pha rmacia, Piscataway, New J ersey) of buffy coat fractions of 
freshly drawn hepa rinized blood 136]. P late lets were routinely removed 
by ce nt rifugation at 60 g in Ha nks' ba la nced salt so lu tions (HBSS) 
(MA Bioproducts) or in some cases by sucrose gradient ce ntrifugation 
[37). T he resultant MNL pellet was resuspended in Du lbecco's mini -
mum essent ial medium containing 25 mM HEPES a nd 2 mM gluta mine 
(DMEM- HEPES) (MA Bioproducts) plus other supplements as de-
sc ribed below. 
Preparation of Adherent M onocy tes and Enriched T Cells 
These enri ched MNL fractions were prepa red as previously desc ribed 
1:38 1. Briefl y, suspensions of 1 x 107 MNL/ ml in DMEM -HEPES plu ~ 
10% huma n AB serum (MA Bioproducts) were incubated at 37"C, for 
J h in t issue cul ture dis hes or fl as ks (Falcon, Oxnard, Ca li forn ia) in a 
humidi fied atmosphere of 5% CO". Nonadherent. ce ll s were removed by 
washing the culture vesse ls 6 tim es with 37"C DMEM-HEPES con-
ta ining 5% human AB se rum . The resul tant. adherent rnonolaye rs 
consisted of > 95% monocytes HS determined by a- naphthyl-es terase 
staining 139]. Enriched T cell s were prepared from the nonadherent 
fraction by E-rosett.ing wit h sheep eryt hrocytes by a previously de-
sc ribed rapid E-rosetting technique j40 j. Lys is of sheep erythrocyte 
by hypotonic sa lin e shock foll owed by reroselt.ing of the rosette-positive 
popul ation yieldeo:d rosett.e-pos iti ve T -cell populations conta ining <2% 
monocytes. 
Production of LJ</ M /( Conlainin~t Supernatants 
Freshly prepa red total MNL or enriched T ce ll" were incubated at a 
concent ration of 1 x 10" cells/ rnl in DMEM -HEPES supplemented 
with 0.5 % huma n serum albumin (HSA) (New York Blood Center, 
New Yo rk , New York ) in t he presence of (a) no stimulant , (b) 12.5 11g/ 
ml co nca nava lin A (Co n A) (Sigma, St. Louis, Missouri ), or {c) 20 ng 
or 20 11 g/m llipopolysaccha ride (LPS) (E. coli 01 28:Bl2, Sigma) at 37"C 
in a 5% COt atmosphere. Cell -free supern atants were collected by 
cent rifugation a fter 24 and 72 h of incubation. MNL viabili ty at these 
Limes was always greater t ha n 80% as assessed by t rypan blue exclusion. 
La rge-scale production was done in 40-ml volu mes in 75-cm" culture 
fl asks, while supernatants used in qua nt itative co mpa riso ns were gen-
erated in 5- ml volumes in 35-mm tissue cul ture dishes (ce ll density or 
5 x 10''/cm2 surface a rea) . Monocyte monolayers used to produce 
supernata nts we re prepared by ad hering tota l MNL at a cell density of 
5 x 10''/cm" to the sa me culture vesse ls and incubatin g as desc ribed 
above. Appropriate concentrations of Co n A a nd LPS were added to 
unstimulated cul ture supernatants immediately a fte r ha rvesting and 
these se rved as cont rol supernatants. Ha rvested supernatants were 
t hen placed in boiled dia lys is tubing (1 2,000- M, cut ofT), and dialyzed 
at 4•c against a total of 109 volumes of di stilled water and a subsequent 
10 volu mes of fresh DMEM before being collected, membra ne fil tered, 
and stored at -70"C until assayed fo r activity. Because the concentra-
tion of Con A in t he generated supernatants was found to have an 
inhibi to ry effec t on all 3 assays of fibroblast fun cti on, a ll Con A-
conta ining superna ta nts were assayed in the presence of 25 mM a-
met hyi-D-mannoside (Sigma), wh ich selectively blocked t.he inhibi to ry 
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effect of Con A whi le having no effect. on cont rol cultures. LPS by itsel f 
had no effect. on the assayed fibroblast functions. However, certa in lots 
of HSA we re found t.o stimul ate fibroblast proliferation, a nd thus t h e 
lots of l-I SA we re screened prior to use and only lots without prolife r -
ative activity were used in the generat ion of superna tants. 
Fibrobla:;t Cultures 
P rimary ce ll cul tures were established from sectioned skin ex pla n ts 
ta ken from the forearms of normal adult volun tee rs as previous ly 
described 129 1. The fibroblasts were grown to co nfluency in H a m 's F-
lO medium containing penicillin (100 U/ ml) , streptomycin (100 p g/ 
ml), glu ta mine (2 mM) , NaH CO,. (1.87 mg/ml) , a nd 10% heat -inacti-
vated feta l calf serum (FCS) (Flow Labs, McLean, Vi rginia) a n d 
subcultured after trypsinization. The fibroblasts used to assess LK/ 
MK activ ity in this study were grown from the papilla ry section of t h e 
dermis and were used between the 4Lh a nd 15th passages. 
A :;say for LJ(/ M J< A ctivity Stimula ting Fibrvblast Proliferation 
Assay of fibroblast proliferative activity was performed in the a b -
sence of FCS using subconfluent fibroblast microcultures (Microtest 
III - Falcon, 3072) in order to optimize assay sensit ivity to proliferatio n 
stimulating signals. Freshly trypsinized fibroblasts were first plated at 
3000 fibrobl asts per microwell in 100 11J of DMEM + 10% FCS fo r 18 
h at 37"C in a 5% C0 2 atmosphere to permit adherence to microwell 
bottoms. Cultures were t hen washed with HBSS and incubated without 
FCS for 48 h in 100 111 fresh DMEM + 0.5% bovine se rum a lbum in 
(BSA) (Sigma) to allow the fibrob last to achieve proliferative quies-
ce ncy. The media was t hen removed and replaced with 200 11l of fresh 
DMEM + 0.5% BSA conta ining va rious dilutions of MNL supernatants 
or gel filtra tion fractions a nd incuba ted for a n addi tional 48 h. Cultures 
were pulsed with 0.5 11Ci ["Hj t hymidine (20 Ci/ mmol, New En gla nd 
Nuclear, Boston, Massachusetts) for the las t 24 h of incubation, and 
the in corporation of I"H]thymidine into DNA was assessed usin a 
methods simila r to those prev iously reported 111- 14]. Briefly, fo llowin~ 
media aspiration , cultures were t rypsini zed , harvested onto glass fiber 
lil t.e rs usin g an automated harvest , lysed by washing with distilled 
water, and t he ["H]thymidine- labeled DNA trapped by t he glas fiber 
filters counted using liquid sc in t illation spectrometry. All sample dj-
lu tions were assayed in triplicate and media cont rol cultures cont.a inina 
no MNL supernatant cha racteristica lly gave mean values for I"HJ 
thymidine incorpora tion of 800- 1200 cpm. 
Assay for LJ(/ M /( Act1:vit.y In hibiting Fibroblast Proliferation 
Assay of fibroblast-growth inhibi tory activity was performed usin g 
microcul ture techniques as described for t he stimulation of prolifera-
tion assay. However, a fter 18 h adherence, media was removed a nd 
then dilu t ions of MNL supernatants or column fractions in 200 11l fresh 
DMEM + 10% FCS were added to the fibrob last cultures for 24 h a long 
with 0.5 11 Ci of ["H]thyrnidine. After 24 h incubat ion !lbroblasts were 
harvested a nd ["H !thymidine incorporation quant itated as before. Me-
dia control cultures containing no MNL supern ata nt gave means of 
approx imate ly 10,000 cpm (fibroblas t. growth induced by FCS). 
Assay for LJ</ M J< Activity I nh ibitin.g Fibroblast Collagen Production 
Assay of co ll agen production was performed using fibrobla st micro-
cul tures of ident ica l co ndition a nd duration as those used to measure 
stimulat ion of proliferation except that. 12,000 fibroblas ts were plated 
per well to produce a confluent monolayer. The media used in plating 
and culturin g t hese monolayers was addjtionally supplemented with 50 
pg/ml ascorbic ac id a nd the cultures were pulsed with 1.0 1• Ci of [3 H ] 
proline (5 Ci/ mmol, New England Nuclea r) in the presence of 50 pg/ 
ml of {:i-aminopropionitrile for the te rmina l 24 h of culture. The 
inclusion of [:1-aminopropioni t.ri le ensures that the majori ty of collagen 
produced will be secreted into t he cul ture media 141) . Determination 
of l"H]proline incorporation in to collagen was performed usin g methods 
similar to t hose previously desc ribed [42). Brieny, t he ext racellular 
I"H]proline- labeled collagen was extracted by t he addi t ion of acetic 
ac id -pepsin to t.he culture media in eac h microwell and purified by 
successive sa lt precipitations at ac id a nd neut ra l pH. The fin al washed 
prec ipi tate was solubilized in 0.5 M acetic acid, inco rporated in to a 
scin ti llation coc kta il , and counted in a liquid scintillation counter. 
Media co ntrol cultures co nta ining no MNL supernatant gave means of 
1000- 1500 cpm. This assay was done in 0.5% BSA instead of FCS and 
at conf.luency in order t.o be able to assess t.he effect of LK/ Ml.; 
containing samples on co ll agen production in t he abse nce of their 
effects on fibroblast proLiferation. 
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Quantitativi' Comparison of LK/M /(Containing Supernatant.s 
Log-linear di lution analys is was used to eva luate the LK/ MI< activ· 
ity produced under different cu lture conditions and to quantitative ly 
compare the levels of LI< / MK produced by normal volun teers and PSS 
patients. Linear regre~sion lines we re generated for each LK/ MK 
supernatant by first. assaying in t riplicate the ["Hjthymidine or ["HJ 
proline incorporAtion induced by a se ries of !i 3-fold dilutions (1:1.7 to 
1:135) of each supe rn ata nt and then plotting the mea n l"H ]thymidine/ 
pro line data agai nst. the log Ill of each of t.he 5 dilutions. For the 
inhibition assays supernatant activit y was compared at the dilution 
causin g 50% inhibition (10,,0) of the coun ts obta in ed in medi a control 
cu ltures without supernatant , wh ile LK/ MK supernatants stimulating 
pro li ferat ion were compared <J t the dilution ca using a .')00% st imulat ion 
(SD 5 oo ) ove r med ia controls, and results are presented as the 10,,0 or 
SD,00 . The compariso n of the LK / MK levels produced by a series of 
norma l voluntee rs and PSS pHtients was further standardized by com-
paring t he regression line for each LI</ MK supernatant to that gen· 
era ted by n sta nda rd supern at-a nt obtai ned from the MNL of 1 normal 
donor. The standard supernatants were always produced, processed, 
and assayed simul ta neously with each group of norm al or PSS super· 
natants tested. Based on the 1Dr.0 and SD,,x, the standard supernatants 
were arbitrari ly asssi~ned a value of 1.0 unit / ml and the levels of LI</ 
MK in the other te t.ed supern ata nt s are expressed as relative uni ts/ 
ml. 
Gel Filtration Chromatography of Lf(j J\11/( Supernatants 
Fifty milliliters of ex haustively dialyzed Ll</MI< supernatant was 
conce n t rated to dryness by lyop hi lization and redi ssolved in 2 ml of 
sterile 0.0 l M sodium phosphate-bu ffered sa line, ph 7.4 (PBS). This 
concentrated amp le was appl ied to a column (diameter 1.6 em , length 
95 em) t hat was pac ked with Sephac.v l S-200 (P harmacia). The samples 
were e luted with PBS co nta ining .01 % polyethylene glycol GOOO against 
gravity at a fl ow ra te of 10 ml/ h. Fractions of 5.0 ml were co llected and 
tested fo r activity without further processing. All chromatograp hic 
procedures were performed at 4 "C. 
RESULTS 
Stimulation of MNL to Produce Fibroblast-!nhibitol)' LK/MK 
Supernatants 
In order to be able to assess the effect of fibroblast- inhibitory 
LK/MK on fibroblast function without interference from the 
presence of contaminating fibroblas t-s timulatory factors, we 
attempted to estab lish MNL culture condi t ions t hat would 
allow t h e production of LK/MK supernatants that exclus ively 
inhibited fibroblast pro liferation and coll agen production. Pre-
liminary investigations indicated t his could best be done by 
stimulati ng MNL with LPS to produce MK supernatan ts and 
with Con A to produce LK supernata nts us ing the culture 
conditions described in Materials and Methods. HSA was cho-
sen as the medi a supplement for LK/ MK production instead 
of serum because H SA maintained the metabolic integrity of 
the MNL whil e having no effect on fibroblast proliferation or 
collagen production, which greatly simpli fied the interpretation 
of the subsequent assays of supernatant activity on fibroblast 
functions. The results as presented in Table I show t hat MNL 
stimulated with either 20 11g/ ml LPS or 12.5 ll·g/ml Con A 
produced supernatants that inhibited both FCS-driven fibro-
blast proliferation and t he extracellular co llagen production 
occur ring in confluent proliferatively quiescent fibroblast cu l-
tures. The production of both inhibitory factors was time-
dependent and was at a maximum after 72 h of cu lture. In 
genera l the act ivi ty of LPS-induced supernatants was greater 
than Con A-induced supernatan ts and the inhibition of prolif-
eration caused by both factors was gene rally greater than their 
inhibition of collage n production. Under the assay conditions 
employed, no LPS- or Con A- induced supernatants stimulated 
coll agen production nor did Con A-induced supernatants stim-
ulate fibrob last proliferation sign ificant ly more than did control 
supernatants. However LPS-induced supernatants did signifi-
cant ly stimulate fibroblast proliferation, with 24- h superna-
ta nts being more potent t han supernatan t generated for 72 h, 
which is likely due to t he increased production of inhibi tory 
factors after 72 h of culture. Thus we were able to generate Con 
A-induced LK supernatants t hat exclusively inhibited fibro-
blast proliferation and collagen production but our LPS-in-
duced MK supernata nts were contaminated with activity stim-
ulating fibroblast proliferation. However, further preliminary 
investigations revealed t hat MNL stimulated with low concen-
trations of LPS (Table 1-20 ng/ml LPS) produced superna-
tants t hat stimulated fibroblast proliferation but did not inhibit 
fibroblast proliferation or collagen production . Such superna-
tants conta ined maximum proliferation-stimulating activity 
after only 24 h of cu lture and moreover the amoun t of activity 
was similar to t hat found in 24-h supernatants induced with 20 
11g/ ml LPS. This observation made it possible to independently 
assess the proliferation-stimulating componen t contaminating 
our LPS-induced fibrobl ast-in hibi to ry MK supernatants. 
Table I a lso illustrates that supernatants from unstimu lated 
MNL contain on ly minimal activity in a ll 3 of our fibroblast 
assays. It should be noted t hat this is true only if endotoxin-
free media and supplements are used, as endotoxin contami-
nation as low as 0.1 n g/ml induced t he production of superna-
tan ts t hat stimulated fibroblast proliferation (data not shown). 
Such endotoxin contamination may be responsible for the 
previously reported spontaneous production of some fibroblast-
regulatory factors [13, 16,21,41] as has been reported fo r other 
MK [43]. Minor platelet contam ination had no effect on t he 
act ivity of generated supernatants as supernatants produced by 
MNL tota lly dep leted of platelets by sucrose gradient centrif-
ugation had t he same levels of activity as did supernatants 
produced by MNL depleted of platelets by centrifugation in 
HBSS at 60 g (not shown). 
TABLE I. Stimulation of MNL to produce lymphohinejm.onohin.e (U </ Ml<) supernatants" 
Pibroblast assay 
Hours of S timul a tion of Inh ibition of Inhi bit ion of Stimula nt 
st imul (ltion proliferation proliferat ion cotla"cn product ion 
SDr,oo b Sl.,,.' lD.o d 11 .,,," !Dr,o ,, ll ,,,.. 
------
None 24 < 1:1.7 1.8 < 1: l. 7 1.0 < 1:1.7 0.98 
72 <1: 1.7 1.6 < 1:1.7 0.92 <1:1.7 0.95 
LPS-20 ng/ml 24 1:19.2 9.8 < 1:1.7 0.95 <1:1.7 0.92 
72 1:20.8 10.7 < 1:1.7 0.88 <1: 1.7 0.87 
LPS-20 ,ug/ml 24 1:14.9 9.0 1:1.9 0.4 7 < 1:1.7 0.68 
72 1:1.8 5.2 1:17.2 0.18 1:9.8 0.29 
Con A- 12.5 11g/ ml 24 < 1:1.7 2.4 <1:1.7 0.75 <1: 1.7 0.82 
72 <1:1.7 2.0 1:8.9 0.27 1:5.3 0.35 
a Representa tive experiment showing the effects of Ll</ MK. upernatants produced by total MNL stimulated with LPS or Con A for 24 or 72 
h on 3 independently assayed fibroblast fun ctions. 
b Supernatant di lution inducing a 500% increase over media controls. 
' Maxim um stimulation index (cpm supernatant/cpm med ia control) induced by a 1:1.7 supernata nt dilution. 
a Supernatant dil ution inducing a 50% dec rease from media co ntrols. 
' Maximum inhibition index (cpm supernat.ant/cpm media control) induced by a 1:1.7 supernatant dilution. 
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TABLE II. Production uf fibrublast -inhibilory lympho/;ine/mono11ine (LK/ M KJ su.pemotants by enriched m.onocyt.es and T cell:<" 
Fibroblast assay 
Hours of s~imu l ation of J nhibit ion of Inhibition of 
s timulati on prolircrat.i on° prolif'eraLion'" co llagen procluclion'" Stimulant 
Monocyte TCell Monocyte T Ccll Monocyte T Ce ll 
No ne 24 < 1 :1.7 < 1:1.7 <1: 1.7 < 1:1.7 < 1:1.7 < 1:1.7 
72 < 1:1.7 < 1 :1.7 < 1:1.7 < 1:1.7 < 1:1.7 < 1:1.7 
LPS- 20 ng/ ml 24 1:10.2 < 1 :1.7 < 1:1.7 < 1: 1. 7 < 1:1.7 < l:l.7 
72 1:11.5 < 1:1.7 < 1:1.7 < 1:1.7 < 1:1.7 < 1:1.7 
24 1:8.5 < 1:1.7 1:1 .8 < 1:1.7 < 1:1.7 < 1:1.7 
72 1:1.8 < 1 :1.7 1:9.6 < 1:1.7 1:4.5 < 1:1.7 
LPS-20 pg/ml 
24 < 1: 1. 7 < 1:1.7 < 1:1.7 < 1:1.7 < 1:1.7 <1: 1.7 
72 < 1:1.7 < l :1.7 < 1:1 .7 1:5.1 < 1: 1.7 1:3.3 
Con A- 12.5 pg/m l 
"Repre,e nt.ative experiment. showing t.he el'fecL of LK/MK supernatants produced by enriched monocytes and T cells stimulated with LPS or 
Con A for 24 or 72 h on 3 independenLly assayed fibroblast funct ions. 
1
' Va lues li sted are the supernatant. dilution inducing a 500 % increase ove r media controls (80,,00 ). 
'Values listed are the supernatant. di lution inducing a 50% decrease from media controls (10,,0). 
In order to insure that ["H ) thymidine incorporat ion is a true 
co rrelate of fibroblast growth as has been reported by others 
[11,13,14], we studied the effect of LK/MK supernatants on 
fibrob last pro liferation by continuously culturing subconf1uent 
fibroblasts in fresh-dai ly 1:2 di lut ions of supernatant for 6 days 
and then counting t he resu ltant cell popu lat ion . Such experi-
ments showed that fibroblasts grown in 72-h LPS (20 11g/ml) 
or Con A-induced supernata nts conta ined only one-half to one-
quarter as many cells as cultures grow n in 10% FCS. The LK/ 
MK-treated fibrob lasts were sti ll viab le as judged by trypan 
blue exclusion and t hus at these concentrations fibroblast in -
hibitory LK/MK appear to be cytostatic rather than cytotox ic. 
F ibrob lasts cultured in 24- h LPS (20 ng/ ml) -induced superna-
ta nts for 6 days contained tw ice as many cells as t hose cul tured 
in DMEM-BSA alone (data not shown). Thus our ["H]t hymi-
dine incorporat ion assay is a true corre late of fibroblast growth. 
Wh ile the ["H)proline incorporation assay specifi cally mea-
sures the newly formed collagen in fibroblast microcu ltures 
[ 42], it does not reveal how the LK/MK supernatants are 
inhibiting collagen production. T he LK/MK supernatants may 
actually be inhibit ing collage n synthesis as suggested by others 
[21,22] or, alternatively, they may be stimulating intracellular 
degradation of newly form ed coll agen or simply decreasing t he 
in tracellular pro line poo l size. 
Production of Fibroblast-Inhibito1y LK/ MK S upernatants by 
Monocytes and T Cells 
In order to confirm t hat total MNL produce supernatants 
containing predomi nately fibrobl ast-active MK when stimu-
lated with LPS and LK when stimulated with Con A, it was 
necessary to fractionate MNL in to adherent monocytes and E-
rosette-posit ive T cells. T he enriched mo nocytes and T cells 
were t hen stimulated with LPS and Con A and t he supernatants 
ge nerated assayed for activity as described in Materials and 
Methods. T he resul ts reported in Table II indicate t hat active 
supernatants were ge nerated on ly by LPS-stimulated mono-
cytes or by Con A-stimulated T cell s. Stimulation of T ce lls 
wit h LPS or monocytes with Con A produced supernatants 
with only minimal activity. Cons istent with previous reports of 
endotoxin contamination of some preparations ofT -cell mito-
gens [44], we fo und some lots of Con A contained endotoxin 
contamination and t he use of such lots erroneously demonstra-
ted stimulation of MK production by Con A (data not shown). 
Such endotoxin contamination may a lso be responsible for 
previously reported production of fibroblast-proliferat ion reg-
ulatory factors by monocytes after PHA or Con A stimulation 
[16,45]. Table II also shows t hat Con A-stimulated T cell s 
produced supernatants t hat exclusively inhibited fibroblast pro-
liferat ion and collage n production at t he same times as Con A-
stimulated total MNL. Likewise, monocytes stimulated with 
either high or low concent rations of LPS produced superna-
tants with t he same activities and at t he same t imes as did t he 
TABLE Ill. Inhibition of fibroblast collagen production in the absen ce 
of inhibition of proliferation" 
In hibit ion of coll agen product ion H~:;;ay 
Supernalan t u I' H !Thymidine 1'11-1 !Proli ne 
inco rpora t iun t· incorporationr 
Media control 949 ± 84 1231 ± 204 
Control 24 h 1023 ± 135 1307 ± 14 
Control 72 h 1081 ± 220 1185 ± 95 
LPS 24 h 1283 ± 224 610 ± 36 
LPS 72 h l.l 66 ± 72 254 ± 28 
Con A 24 h 996 ± 65 1005 ± 12f' 
Con A 72 h 1291 ± 146 304 ± 34 
"Experiment show ing the effect of LK/ MK supernata nts produced 
by total MNL stimulated with 20 pg/ml LPS or 12.5 lt.g/ ml Con A for 
24 or 74 h on proliferatio n and collagen production of flbrob la ts 
cul tured usin g the conditions listed for the inhibition of collagen 
production assay. 
''Supernatants were tested at a dilution of 1:1.7. 
' Values listed are triplicate means ± SO of cpm incorporated. 
LPS stimulation of total MNL. Thus, with our cult ure condi-
tions, it appears t hat LPS stimulation of total MNL results in 
fibroblast-regulatory MK production , while Con A stimulation 
results in LK generation. 
Fibroblast-Inhibitory LK/ MK Supernatants Inhibit Collagen 
Production Without Inhib iting Fibroblast Proliferation 
Since our collagen production assay employed t he use of 
quiescent conf1uent fibroblast cul tures we were able to assess 
t he effect of fibroblast-inh ibi tory LK/MK supernatants on 
coll agen production in the absence of their effects on fib roblast 
proliferation. Data in Table III illustrate t hat both LPS-in -
duced inhibitory MK supernatants and Con A-induced inhibi-
tory LK supernata nts inhibi ted collagen production independ-
ently of inhibition of fibroblast proliferation. Thus the MK and 
LK inhibi t ing collagen production likely act t hrough mecha-
ni sms unrelated to tibroblast proliferation, which suggests that 
the factors inhibi t ing collagen production may be distinct mol-
ecules from those inhibi t ing proliferation. 
Gel Filtration Chromatography of Fibroblast-Inhibitory LK/ 
MK S upernatants 
To obtain estimates of t he M, of the monocyte- and T cell-
derived factors inhibi t ing fibroblast proliferation and collagen 
production, LK/MK supernatants were chromatographed on a 
Sephacryl S-200 column. Chromatography of LK supernatant 
produced by total MNL stimulated for 72 h with 12.5 llg/ ml 
Con A eluted a broad peak of activity inhibiting fibroblast 
proliferation in t he M ,. range centering a round 50,000 (Fig 1). 
In contrast, the MK inhibiting fibroblast proliferation obtained 
by 72-h stimulation of total MNL with 20 11g/ml of LPS, eluted 
in a peak centered around M, 20,000 (Fig 1) . The elution of 
Nov . 1984 FIBROBLAST-I NH IBITORY LYMPHOKINES/MONOKINES AND PSS 381 
r<) 
'o 
X 
E 
0.. 
'-' 
z 
0 
I 0 t-
Vo 
' 
150K y 43 K y 25K 137K 
' ' 
a 
-. 
/ ' fl'. ., 
--~~~-----~--------~~~~,---------- ---~---8 f-- ........ _ ,• • • ... • •-.... 
6'-
41--
·-·-.- '· I 
\ . 
f---HSA----1 
·,. I 
' . 
·' . ... . ! 
I I I I I I I I I I I I I I I 
20 25 30 35 40 45 50 55 
FRAC T ION NUMBER 
F IG L Sephac ryl S-200 chromatography of supernata nts produced 
by total M N L sr.im ulat.ed for 72 h with: (a) 20 l'g/ ml LPS; (b) 12.5 1•g/ 
ml Con A. Column fractions we re assayed at a dilu t ion of 1:4 for 
inh ibitio n of ["H] t h,v midine incorporation by fibroblas ts cu ltured in 
med ia conta ining 10% FCS as deta iled in M'aterials and Methods. 
(Medi a cont rol is represented by t he dashed horizontal line). M, ma rke rs 
were v " (b lue dextra n); !50!( (a ldolase); 43 /( (ovalbum in); 25!( (chy-
motrypsi noge n); a nd 13. 71( (ri bonuc lease). 
activ i ty that inhibi ted collagen production pa ralleled t hat 
which inhibi ted fibroblast proliferation wi th t he majori ty of 
Con A -induced coll agen-inhibit ing activity contained in theM, 
50,000 r ange and t he LPS- induced activ ity inhibit ing collagen 
produ ction in the M, 20,000 range (data not shown ). Both 
inh ibi tory activit ies contained in the Con A-induced superna-
tan t were tota lly recovered in t he M, 50,000 peak but the M, 
20,000 peak conta ined less t han 50% of the applied LPS-
indu ced activit ies. Loss of activity in t he M, 20,000 range may 
be d u e to nonspecific adso rption to polystyrene collection tubes, 
an occurrence which -would be prevented by coelut ion of HSA 
in t h e M, 50,000 range. The inhibitory activit ies of t he M, 
50,000 peak fraction were not due to t he concent ration of HSA 
presen t nor were t hey due to t he possible presence of eluted 
Con A dimer, as t he activity of t hese fractions was unaffected 
by con centrations of a -methyi-D-mannoside from 25- 100 mM 
(data n ot shown). 
T h e c hromatographic data fur ther demonstrate that stimu-
lation of total MNL with Con A and LPS preferent ially pro-
duced LK and MK, respecti vely. Con A supernatants conta ined 
only Mr 50,000 LK inhibitors and no M, 20,000 MK inhibitors, 
while LPS supernatants were only minimally contaminated 
with L K inhibitors of M , 50,000. Thus, alt hough supernatants 
from Con A-stimulated total MNL have been reported to 
contain certa in immunoregulatory MK as a resul t of LK-
trigger e d production [ 46], t his appears not to be t he case for 
these fibr oblast-inhibitory LK/ MK. 
Aberrant Production of the LK and MK Inhibiting Fibroblast 
Prolife ration by MNL of PSS Patients 
Sin ce L K/ MK production is known to involve t he in teraction 
of diffe r e n t MNL subsets through a LK/ MK cascade mecha-
nism [ 46 ], we chose to investigate t he levels of fibroblast-
inhibitory LK and MK produced by PSS patients using total 
MNL rather than enriched popu lations in order t.o optimize 
our chances of detecting a defect in LK/ MK production. Total 
MNL from a series of normal volu nteers and PSS patients 
were stimulated with: (a) 20 ng/ ml LPS for 24 h to produce 
supernatants contain ing exclusively pro liferation stimulatory 
MK; (b) 20 11g/ ml LPS for 72 h to produce prol iferation / 
collagen production inhi bitory MK; and (c) 12.5 ,ug/ ml Con A 
for 72 h to produce exclusively proliferation/ collagen produc-
tion inh ibitory LK. The potency of each generated supernatant 
was compa ratively qua ntitated and expressed as units/ ml as 
desc ribed in Maten:als and Methods. The results presented in 
Fig 2 show that MNL from the series of PSS patients produced 
signi fica ntly less t han normal amounts of t he Con A- induced 
LK that inh ibits fibrob last proli feration. The 14 normal vol-
un teers produced 1.01 ± .22 (SD) uni ts/ ml of t he factor while 
t he 13 PSS pati.ents produced only 0.51 ± .29 units/ ml (p < 
.001 by two-tailed Student's t-test). If only t he 11 of 13 PSS 
patients outs ide 2 SD of the norma l mean are considered, the 
average is 0.41 ± .16 uni ts/ml (p < .001). T hus it is evident 
that PSS patients produced fibroblast pro liferation inhibitory 
LK in levels markedly lower than cont rols. T his, however, was 
not true for the co llagen production inhibitory LK as Fig 3 
shows that the levels of this facto r produced by normal vo lun-
tee rs (1.02 ± .36 uni ts/ml) and PSS patients (1.06 ± .30 units/ 
ml) to be similar. T his observation further suggests t hat t he 2 
fibroblast- inhibitory LK are separate molecules. 
Data illustrated in Fig 2 also show that MNL from PSS 
patients produced markedly elevated levels of the LPS- induced 
MK that inhibits fibroblast proliferation. Normal volunteers 
produced an average of 1.15 ± .31 units/ml while PSS patients 
produced 2.96 ± 1.46 units/ml (p < .001). The 9 of 13 PSS 
patients producing levels greater t han 2 normal SD averaO'ed 
3.83 ± .66 uni ts/ml (p < .001) and all 9 of t hese patients w~re 
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FIG 2. Compa rative production of t he MK a nd LK in hibiti ng- fi bro-
blast. p roli feratio n by tota l MNL of normal voluntee rs and PSS pa -
tients. MK supe rnatan ts were produced by stimulation wit h 20 l'g/ ml 
LPS fo r 72 h and LK supernatants by stimulation wi t h 12.5 l'g/ ml Con 
A for 72 h. Inhi bitory activity was qua nt,itated as desc ribed in Mat erials 
and Methods a nd expressed as uni ts/ ml. T he longer horizontal dashed 
bars indicate t he ove ra ll means of each group while t he shorter horizon -
tal dashed bars indicate t he mea ns of t hose PSS va lues outside 2 SD of 
the norma l mea ns. 
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also hypoproducers of t he proliferation inhibi tory LK. The 
increased fibroblast pro liferation inhibitory capacity of PSS 
MNL supernatant was not due to t he presence of decreased 
amoun ts of contaminating proliferation-stimulating MK as 
PSS MNL stimulated with 20 ng/ml LPS for 24 h produced 
normal levels of the proliferat ion-stimulatory MK as shown in 
Fig 3 (normal 0.99 ± .32 uni ts/ml; PSS 1.11 ± .33 units/ml). 
Thus PSS patients tru ly produced increased leve ls of the fibro-
blast proliferat ion-inhi bitory MK. T hey did so whi le producing 
normal amou nts of t he coll agen production inhibi tory MK, as 
deta iled in Fig 3 (normal 1.12 ± .29 un its/ml; PSS 1.10 ± .21 
uni ts/ml ). T hi s latte r observation suggests that the MK inhib-
iting fibrob last prolifera t ion may be different from the MK 
inhibit ing coll agen production. 
DISCUSSION 
T he studies described here were undertaken to evaluate t he 
capac ity of normal peripheral blood MNL to produced LK and 
MK inh ibit ing fibroblast proliferat ion and coll agen production, 
and to subsequently compare t he normal levels produced with 
those generated by MNL from PSS patients. Our resu lts indi -
cate t hat normal MNL stimulated with Con A produce T cell -
derived LK supernatants t hai exclusively inhibit fibrobl ast 
proli feration and coll agen production (Tables I, II) . The prolif-
eration-inhibito ry LK may be a dist inct molecu le from that 
inhibit ing co ll agen production as inhibition of coll agen produc-
tion was demonstrated in t he absence of effects on proli feration 
(Table Ill). However both the proliferation- and co ll agen-
inhibi t ing activit ies coeluted in theM, 50,000 range on Sephac-
ryl S-200 chromatography (F ig 1) . T his M , estimate is in 
agreemen t with t hose previously published for both LK-inhib-
itory activit ies [15,21 ]. Why LK activity stimu lating fibroblast 
proliferation or collage n production could not be detected in 
our Con A- induced supernatants was not investigated. The 
absence, however, may be due to t he fact t hat only minimal 
production of stimulatory LK occurs at t he low MNL density 
(5 x 10''/c m" surface a rea ) used in our generation cul tures, as 
t hose reporting ge neration of stimulatory LK have used eit her 
high density su rface cul tu res (4 X 10"/cm1 ) or t he even higher 
density grav ity sedimented pe ll ets t hat form during t ube cul tu re 
generation [11,12,17]. 
Supernata nts inh ibiting both fibrob last proli feration and 
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collagen production were also produced by st imulating normal 
MNL with 20 J.Lg/ml LPS (Table 1). Whi le t hese supernatants 
were shown to contain exclusive ly monocyte-derived products 
(Table II) , t hey also contained a fibroblast proliferation stim -
ul atory MK which could also be produced in the absence of 
inhibitory MK by stimulating MNL with only 20 ng/ ml LPS 
(Tables I , II). T he collage n production inhibitory MK was 
active in t he absence of effects on proliferation (Tab le III) and 
both MK inhibito ry activit ies coeluted from a Sephac ryl S-200 
column in t he M, 20,000 range, further suggesting t hat t he 
inhibitory MK are molecu les distinct from the inhibitory LK. 
Th is repo rt represents t he first estimation of the M , of t he 
LPS-induced MK inhibiting fibrob last proli fe ration and colla-
gen production, although 2 previous studies have estimated the 
M, of spontaneously produced (e ndotoxin conta mination in-
duced?) MK that inhibit growth and/or collage n production by 
inducing prostaglandin synt hesis at 12,000- 20,000 [16] and 
20,000- 30,000 [22]. 
However, the mechanism of act ion of t he fibroblast-inhibi-
tory LK and MK described in this report, and t heir relation to 
known immunoregulatory LK/MK remain open to speculation 
until t hey have been more extensive ly characterized as to t heir 
cellular sources and biochemical properties, although several 
immunosuppressive LK/MK with M , similar to our fibroblast-
inh ibitory facto rs, including the in terfero ns (47] and t he soluble 
immune response suppressors (48] exhibi t an t iproliferative ac-
tivity on cell s of nonimmune origin . However, in some other 
instances t he coidentity of fibroblast-regu latory LK/MK and 
immunoregu latory LK/MK has been proved. Evidence has 
been presented identifying fibronecti n as t he macrophage-de-
rived fibroblast chemotactic factor and hu man monocyte-de-
rived fibroblast proli fe ration stimulatory activity can be attrib-
uted to interleukin 1 [9 ,14]. Conversely, studies in guinea pigs 
indicate that T ce ll-derived llbroblast proliferation stimulating 
activity is distinct from inte rl eukin 1 [12] and human T cell -
derived fibrob last prolife ration inhibition factor appears to be 
distinct from a- lymphotoxin [15]. 
Recent studies indicated that pathologic fibrosis is accom-
panied by LK/MK production in vivo, as act ivated monocytesj 
macrophages and activated T cells t hat spontaneously produce 
fibrob last growth factors have been iso lated from the fibrot ic 
synovium of rheumatoid arthritis patients and from t he lungs 
of patients with idiopathic pulmonary fibrosis [23,24]. In vivo 
LK/MK production in PSS is suggested by t he presence ofT-
cell blasts among the infi lt rating MNL in affected t issue sites 
(6] and by the presence of factors with LK/ MK activity (fibro-
blast proliferation stimulation, collagen production stimula-
tion, and proliferation inhibition) in t he se rum of PSS pat ients 
[49- 51] . While t hese studies verify that in vivo "auto-ant igen" 
activation ofT cells and monocytes/macrophages results in t he 
production of fibrob last- regu lato ry LK/ MK, t hey do not ind.i-
cate whether t he normal balance of stimulato ry and inhibitory 
LK/MK is altered in cases of pathologic fibros is. 
In contrast, t he resul ts of our in vitro study reveal t hat 
peripheral blood MNL from patients with PSS in addition to 
having a diminished capacity to produce the LK inhibiting 
fibroblast prolife ration , also possess t he enhanced capacity to 
produce t he analogous MK (Fig 2). T he aberrant production of 
these 2 fibroblast proliferation inhibitory facto rs occurred in 9 
of 13 PSS patients studied. This characteristic PSS LK/MK 
production was independent of age as patients of all ages, 
including one 20-year-old and one 75-year-old, exhibi ted t his 
aberrant production pattern. Whether t his aberrant LK/MK 
production occurs only in PSS or is also characteristic of other 
chronic fibrot ic di seases remains to be investigated. However, 
in PSS the aberrant production of these 2 fibroblast prolifera -
tion inhibito ry factors did occur in t he presence of t he produc-
tion of normal levels of both the MK stimulating fibroblast 
proliferation and the LK and MK inhibiti ng fibroblast collagen 
production (Fig 3). 
Nov. 1984 FIBROBLAST-INHIBITORY LYMPHOKINES/ MONOKINES AND PSS 383 
While the mechanisms responsible for the observed aberran t 
production of both T cell -derived and monocyte-derived prolif-
eration inhibi to ry factors likely involve t he complex in teraction 
of c ells and mediators regulating the LK/ MK cascade, recent 
reports suggest 2 plausible, although possibly simplified, expla-
natio ns. Firstly, a number of studies suggest t hat the increased 
B -cell fun ction associated wi th autoantibody formation in PSS 
may be t he resul t of a deficiency of circulating T suppressor 
cells [30-32]. Since T suppressor cells are a likely source of our 
prolifera tion inhibitory LK, t hen a deficiency ofT suppressor 
cells could explain why we have observed a deficient production 
of th is LK in PSS patients. Secondly, other studies have 
suggested t hat t he depressed T -cell functions associated with 
PSS may be the resul t of t he increased activity of suppressor 
monocytes [33,34]. These hyperactive suppressor monocytes 
may be the source of the increased levels of the proliferation 
inhibitory MK produced by a port ion of our PSS patients. Such 
suppressor monocytes have also been described in murine 
models of graft-versus- host disease, where they were associated 
o nly with t he later stages of t he disease [52]. Whether suppres-
sor monocytes are present only in PSS pat ients of long duration 
has not been investigated, but this may be t he case if our results 
are indicative of increased suppressor monocyte activi ty, as all 
the PSS patients we studied had a disease duration of 3 years 
or more with a group mean of 9.6 years. 
A ssuming that t he production of LK/ MK in PSS tissue sites 
parallels t hat which we have observed with peripheral blood 
MNL, then our results suggest t hat t he increased fibroblast 
popu lation seen in early PSS tissue sites is due to t he deticient 
p roduction of a fibroblas t p roliferation inhibi tory LK, allowing 
excess fibr oblast-growth stimulatory signals to unrestrictedly 
expand the resident fibroblast population. In vivo, the growth-
stimulating signals may include not only stimulatory LK and 
MK, but also platelet-derived growth factor (PDGF) as studies 
su ggest that the vascular endothelial damage occurring in PSS 
results in the perivascular aggregation of platelets and the 
subsequent discharge of PDGF into PSS tissue sites [53]. Our 
results furt her suggest t hat t he increased fibroblast growth 
cau sed by t his relative excess of fibroblast-proliferation stim-
ulatory signal s is moderated in long-term PSS patients by the 
increased production of a fibrobl ast-growth inhibitory MK 
S u c h a mechanism would play a role in limit ing previously 
init iated fibrosis and could be responsible for t he more stabi-
lized forms of PSS often seen in long-term patients. Proof of 
t his theory, however , requires investigation of t he levels of 
fibroblast proliferation inhibitory LK/ MK produced by pa-
t ients with newly acquired PSS. 
Our results also show that t he production of t he LK and MK 
inhibiting fibroblast collagen production is normal and thus 
t hese 2 factors cannot be implicated in t he induction of the 
portion of PSS fibrob lasts which possess a hyper-collagen-
producing phenotype. However, other studies suggest t hat this 
phenotypic change may be caused by t he excessive production 
of a collagen production stimulatory LK by PSS MNL [54,55) 
or, a lte rnatively, t hose fibroblasts t hat have been induced to 
proliferate by t he relative excess of PDGF may innately possess 
t he hyper-collagen-producing phenotype [56]. Thus both t he 
increased fibroblast number and the increased fibroblast func-
tion observed in PSS tissue sites appea r to be t he result of 
system ic immunologic abnormali t ies exacerbating an in s itu 
i.nflammatory response by causing t he unbalanced production 
of stimulatory and inhibito ry fibroblas t -regulatory LK/ MK 
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